Categories
Tags
Abbott Advertising AstraZeneca Barack Obama Big Pharma Biotechnology and Pharmaceuticals Bristol Myers Squibb business Cancer Clinical trial conference Deal Eli Lilly European Commission European Union Facebook FDA Food and Drug Administration Genentech generics GlaxoSmithKline Google GSK HBA Health Health care Johnson & Johnson layoffs Lilly Marketing Merck Novartis Pfizer Pharma Pharmaceutical drug pharmaceutical industry Research and development Roche Sanofi-Aventis Schering Plough social media Twitter U.S. Food and Drug Administration United States Wyeth
Technology News
BioPharm News
Tag Archives: Johnson & Johnson
Feds Chase Down Faulty Skincare Promos
FDA’s Division of Drug Marketing Communications, this week, posted a slew of warning and untitled letters to pharma firms for misleading skincare advertisements. Johnson & Johnson, Galderma, and Allergan each received a letter documenting complaints ranging from false advertising to unsubstantial efficacy claims.
J&J received a violation letter in response to a journal ad for its [...]
Posted in FDA, Marketing Also tagged Advertising, Allergan, Clinical trial, U.S. Food and Drug Administration Leave a comment
Merck/Schering-Plough Merger Highlights (Update 1)
Merck and Schering-Plough’s CEOs are giving a run down of the benefits of the $41.1 billion merger, announced this morning, in a conference call with investors. Here are some of the highlights:
• Total price of the sale will be $41.1 billion or $23.6 per Schering share.
• This deal is structured as a reverse merger with [...]
Posted in Deals, Strategy Also tagged Deal, Merck, Merger, Remicade, Schering Plough, Vytorin 4 Comments
Pharm Exec Podcast Series:
Bill Trombetta Industry Audit (Part 3)
[display_podcast]
Continuing Pharm Exec editor Patrick Clinton’s conversation with Bill Trombetta on the top four pharma companies and what makes them special.
Johnson & Johnson: A perennial member of the Top Four, J&J defies the conventional wisdom; it’s a big company that still manages to grow, a sprawling, diversified company that still has focus. And along [...]
HBA Leadership Conference: Day 1
Reporting to you from Chicago at the Sixth Annual Healthcare Businesswomen’s Association leadership conference, where the story—set in this city of the new US President—is all about change.
The Pharm Exec crew arrived in a surprisingly tranquil Windy City—the only explanation that it was the calm after the storm of Tuesday’s election. Certainly, many HBA members [...]

Pharma and Haiti: Can Altruism Backfire?